Breast cancer is the most frequently diagnosed neoplastic disease in women around
menopause often leading to a significant reduction of these women's ability to function …

Oral contraceptives may influence the risk of certain cancers. As part of the AHRQ Evidence
Report, Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer, we conducted …

Background Little is known about whether contemporary hormonal contraception is
associated with an increased risk of breast cancer. Methods We assessed associations …

Epidemiologic studies have contributed importantly to current knowledge of environmental
and genetic risk factors for breast cancer. Worldwide, breast cancer is an important cause of …

Background Oral contraceptives have been used by hundreds of millions of women around
the world. Important questions remain regarding the very long-term cancer risks that are …

Simple Summary Triple-negative breast cancer (TNBC) is a highly aggressive subtype of
breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy …

Previous studies of oral contraceptives and breast cancer indicate that recent use slightly
increases risk, but most studies relied on self-reported use and did not examine …

Background Evidence on a possible association between newer hormonal contraceptives
(HC) and risk of breast cancer remains inconclusive, especially as concerns progestogen …

Technological change in medicine has complex interactions driven by demand-and supply
side determinants. The epistemological position of this paper is that scientific research …

Background: Evidence suggests that recent oral contraceptive (OC) use is associated with a
small increased breast cancer risk; yet risks associated with contemporary OC preparations …